Core Points - The company is named Ningbo Meinuohua Pharmaceutical Co., Ltd., established as a joint-stock company in accordance with the Company Law of the People's Republic of China [1][2] - The registered capital of the company is RMB 219,822,861 [1] - The company was approved by the China Securities Regulatory Commission to issue 30 million shares to the public in 2017 and was listed on the Shanghai Stock Exchange [1][3] Chapter Summaries Chapter 1: General Provisions - The purpose of the articles is to protect the legal rights of the company, shareholders, employees, and creditors [1] - The company is a permanent joint-stock company [1] - The legal representative of the company is the chairman of the board [1] Chapter 2: Business Objectives and Scope - The company's business objective is to create a leading large-scale biopharmaceutical group with independent intellectual property rights and core competitiveness [1] - The business scope includes the production of tablets and capsules, sales of pharmaceutical raw materials, and research and development of pharmaceutical intermediates [1] Chapter 3: Shares - The total number of shares is 219,822,861, all of which are ordinary shares [3] - The company can increase registered capital through various methods, including issuing shares to unspecified objects or existing shareholders [3][4] - The company is prohibited from repurchasing its own shares except under specific circumstances [4] Chapter 4: Shareholders and Shareholder Meetings - Shareholders have rights to dividends, voting, and supervision of the company's operations [6] - The company must hold an annual general meeting within six months after the end of the previous fiscal year [10] - Shareholder meetings can be called by the board of directors or by shareholders holding more than 10% of the shares [12] Chapter 5: Proposals and Notifications for Shareholder Meetings - Proposals must fall within the authority of the shareholder meeting and be clearly defined [13] - Shareholders can propose temporary motions 10 days before the meeting [13] Chapter 6: Voting and Resolutions of Shareholder Meetings - Ordinary resolutions require a simple majority, while special resolutions require two-thirds of the votes [18] - The company must disclose the results of voting on significant matters affecting minority investors [19]
美诺华: 宁波美诺华药业股份有限公司章程(2025年8月)